The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +30,344.96% increase from the last price of 0.04.
The current consensus among 1 polled investment analysts is to Hold stock in Sorrento Therapeutics Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.19
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.